Physician
Wybenga Family Healthcare, INC.
Wybenga Family Healthcare, INC. was paid $384K by Medicaid between Jan 2018 and Sep 2022, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 64% of everything it billed.
33Billing provider infoWYBENGA FAMILY HEALTHCARE, INC.
PRATTVILLE, AL 36067
PRATTVILLE, AL 36067
33aNPI1710998505assigned 08/10/2006
33bProvider typeFamily Medicine Physician
28Total paid$384K
24GClaims9,334
24DCodes billed17
24AFirst – last monthJan 2018 – Sep 2022
Compared with peers
Next to other Family Medicine Physician providers in Alabama
Rank by total paid#102 of 455
Median peer was paid$57K
This provider vs. median6.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,150 | $58K | |
| 2019 | 2,551 | $83K | |
| 2020 | 1,505 | $68K | |
| 2021 | 1,720 | $94K | |
| 2022 | 1,408 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 64% | 5,155 | 4,359 | $244K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 1,504 | 1,324 | $110K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.1% | 292 | 279 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 385 | 355 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 393 | 360 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 678 | 597 | $1K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 60 | 56 | $998.95 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 31 | 31 | $869.10 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 15 | 12 | $630.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | 13 | $630.00 |
| 81002 | <1% | 212 | 199 | $557.61 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 67 | 54 | $398.75 |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWYBENGA, MAARTEN (OWNER)